Admission Date:  [**2178-2-8**]              Discharge Date:   [**2178-2-11**]  Date of Birth:  [**2106-11-24**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 2704**] Chief Complaint: Pre-cath hydration  Major Surgical or Invasive Procedure: Cartotid angiogram  History of Present Illness: 71 yo F with history of CAD, severe PVD, DM, HTN who presents for pre-cath hydration prior to carotid angiogram.
On further ROS she also notes mild occasional occipital HA, relieved by tylenol and baseline pain in upper thighs at rest [**3-7**] PVD and worse in LE with exertion.
She  has a known occluded RCA CHF- EF 20-25%, ischemic cardiomyopathy, s/p ICD placement in [**2174**] for primary prevention.
Has only discharged once 2 years ago PVD - has symptoms of claudication s/p POBA to L profunda femoral artery, known 99% R SFA and 100% L SFA occulusions small AAA Hypothyroidism DM HTN HLD COPD Asthma history of Bladder Ca - had tumor excision without chemo or radiation Carotid Stenosis: 50-79% right ICA and 70-79% left ICA stenosis on U/S .
Surgical history Appendectomy hysterectomy .
Pulses: Right: Carotid 2+ Femoral 2+ Popliteal 0+ DP 0+ PT 0+ Left: Carotid 0+ Femoral 2+ Popliteal 0+ DP 0+ PT 0+  Pertinent Results: [**2178-2-8**] 05:17PM BLOOD WBC-8.1 RBC-3.87* Hgb-11.2* Hct-31.9* MCV-83 MCH-29.0 MCHC-35.1* RDW-13.9 Plt Ct-233 [**2178-2-8**] 05:17PM BLOOD Glucose-280* UreaN-40* Creat-1.8* Na-134 K-3.9 Cl-93* HCO3-30 AnGap-15 [**2178-2-10**] 06:05AM BLOOD Glucose-280* UreaN-46* Creat-1.8* Na-139 K-5.0 Cl-99 HCO3-32 AnGap-13 [**2178-2-10**] 06:05AM BLOOD CK(CPK)-93 [**2178-2-9**] 05:40AM BLOOD CK-MB-NotDone cTropnT-0.03* [**2178-2-8**] 05:17PM BLOOD Calcium-9.8 Phos-3.2 Mg-2.3 [**2178-2-9**] 05:40AM BLOOD %HbA1c-10.1* [**2178-2-9**] 05:40AM BLOOD Triglyc-582* HDL-30 CHOL/HD-5.9 LDLmeas-70 [**2178-2-8**] 05:17PM BLOOD Digoxin-2.5* [**2178-2-9**] 05:40AM BLOOD Digoxin-3.5*  LENIS [**2178-2-9**]: FINDINGS: Grayscale and Doppler son[**Name (NI) 1417**] of bilateral common femoral, superficial femoral and popliteal veins were performed.
Successful ptca and stenting of the left ICA utilizing spider filter for distal protection.
Successful deployment of a self-expanding  tapering 6-8x40mm protege carotid stent which was post dilated to 4.5mm.
Left ICA was successful ptca and stented utilizing spider filter for distal protection.
Required phenyleprine to maintain BP systolic range 100-140.
Her pressor was weaned the morning following admission.
Her digoxin, amlodipine, lisnopril, lasix and imdur were discontinued until her scheduled outpatient follow up with cardiology.
Her carvedilol was held pre-cath and she was instructed to restart this medication on the day following discharge.
Her digoxin level was elevated and her medication was held.
Her carvedilol was held pre-cath and she was instructed to restart her home dose on the day following discharge.
Concern because mobitz [**6-4**] worsen with vagal stimulation (and carotid stents frequently complicated by high vagal tone so her PCM backup rate was increased to 50bpm as above.
She was continued on aspirin and plavix.
Her lisinopril, amlodipine, and imdur were held as above.
The patient received pre-cath hydration with NS at 60cc/hr ON, more gentle given decreased EF.
Blood pressure medications held as above.
#DM: Continued home glipizide and RISS.
#Hyperlipidemia: Continued on atorvastatin, fenofibrate, and Zetia.
# COPD: Continued Fluticasone and PRN albuterol .
Digoxin 250 mcg PO DAILY 2.
Atorvastatin 60 mg PO DAILY 3.
Levothyroxine 50 mcg PO DAILY 4.
Amlodipine 10 mg PO DAILY 5.
Fenofibrate Micronized 145 mg PO daily 6.
Glyburide 10mg 2 tabs in AM and 1 tab in PM 7.
Furosemide 120mg in AM and 80 in PM 8.
Lisinopril 20 mg PO DAILY 9.
Ezetimibe 10 mg PO DAILY 10.
Pentoxifylline 400 mg  Sustained Release PO TID 11.
Nitroglycerin 0.4 mg Tablet Sublingual PRN.
Fluticasone-Salmeterol 250-50 mcg/Dose One INH [**Hospital1 **] 13.
Albuterol 90 mcg/Actuation Aerosol Sig: One (1)  Inhalation every eight (8) hours as needed for shortness of breath or wheezing.
Clopidogrel 75 mg PO DAILY 16.
Aspirin 325 mg PO DAILY 17.
Carvedilol 25 mg PO twice a day.
Isosorbide Mononitrate Sustained Release 24 hr 60mg qAM, 30mg qhs  Discharge Medications: 1.
Atorvastatin 20 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily).
Levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Fenofibrate Micronized 145 mg Tablet Sig: One (1) Tablet PO Daily ().
Ezetimibe 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Pentoxifylline 400 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO TID (3 times a day).
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 325 mg Tablet, Delayed Release (E.C.)
Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).
Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation Q6H (every 6 hours) as needed.
Glyburide 5 mg Tablet Sig: Four (4) Tablet PO QAM (once a day (in the morning)).
Glyburide 5 mg Tablet Sig: Two (2) Tablet PO qPM.
Nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) Sublingual prn chest pain: take one tablet under toungue every 5 minutes, up to 3 tablets, if still having chest pain, call 911. .
Coreg 12.5 mg Tablet Sig: One (1) Tablet PO twice a day: start on [**2178-2-12**].
L internal carotid stenosis s/p carotid stenting 2.
Hyperlipidemia   Discharge Condition: Good   Discharge Instructions: You were admitted to the hospital for carotid artery stent placement.
Your digoxin, amlodipine, lisnopril, lasix and imdur were discontinued.
However, do not take the following medications until directed to do so by your cardiologist: Digoxin Amlodipine Imdur .
You must continue to take this medication to prevent a blot clot formation in your carotid stent.
You should never stop this medication unless directed to by your cardiologist.
You should also continue to take your aspirin daily.
Dr. [**Last Name (STitle) **] will discuss restarting your blood pressure medications at this time.
